v3.25.2
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Deferred tax assets:    
Capitalized research and development expenditures $ 5,492,204 $ 3,253,225
Net operating loss carryforwards 3,361,350 2,183,803
Research and development tax credits 1,254,707 1,253,836
Capitalized license fees 781,373
Share-based compensation 46,122 24,969
Accruals and other 200,285 13,548
Deferred tax assets 11,136,041 6,729,381
Less valuation allowance (11,136,041) (6,729,381)
Net deferred tax assets